ST6GAL1 and neoplasm: Similarly, tumor growth curves revealed that ST6GAL1 knockdown significantly suppressed tumor progression under anti‐PD‐L1 treatment, whereas ST6GAL1 overexpression slightly dampened this synergistic effect, although the differences were not statistically significant (Figure S5B,D, Supporting Information).